Science
Mechanism of Action
Palmitoyl Tetrapeptide-7 operates by strategically reducing the production of pro-inflammatory cytokines, notably interleukin-6 (IL-6), thereby interrupting inflammatory cascades that accelerate the degradation of collagen and other vital structural proteins. Concurrently, it stimulates the synthesis of essential extracellular matrix components like collagen and hyaluronic acid, directly contributing to restored skin firmness and elasticity. This ingredient further supports skin health by promoting elastic fiber production within the papillary dermis and activating phagocytosis, enhancing natural defense mechanisms and aiding cellular debris clearance.
Research
Clinical Evidence
High confidence0.0015%
Key findings
- 01 A cytometric study involving 17 subjects demonstrated a significant increase in skin firmness (+19% on the face, +40% on the neck) and elasticity (+17% on the face, +27% on the neck) after one month of topical application within a cream formulation.
- 02 Twice-daily application for two months led to a statistically significant reduction in deep wrinkles and skin roughness, alongside improvements in overall skin elasticity and tone.
- 03 In vitro studies observed a dose-dependent reduction in interleukin-6 (IL-6) production, reaching up to a 40% decrease. Further in vitro research indicated an 86% reduction in interleukin production in UV-exposed cells.
Transparency
Dusting Analysis
While the Cosmetic Ingredient Review (CIR) Expert Panel indicates Palmitoyl Tetrapeptide-7 is typically used at concentrations less than 0.001% (10 ppm) and is safe, clinical efficacy for specific anti-aging benefits such as improved firmness and elasticity has been demonstrated at 0.0015% (15 ppm) or higher. Therefore, formulations containing PEI-7 at concentrations below 0.0015% may be considered 'dusting' if significant anti-aging claims are made, as they may not reach clinically effective levels for targeted skin concerns.
The Formula
Formulation
Stability
For optimal stability, PEI-7 is typically incorporated into the water phase during the cooldown stage of formulation, specifically below 40°C (104°F). Its palmitic acid moiety enhances both stability and skin penetration.
Conflicts
- Zinc Oxide
- Phytic Acid
- Butylene Glycol Dicaprylate
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel concluded that Palmitoyl Tetrapeptide-7 is safe for topical use in cosmetics at typical concentrations below 0.001%. It is generally associated with a low risk of irritation or sensitization. However, individuals with highly reactive skin are advised to perform patch testing. Due to its palmitic acid base, caution is advised for those susceptible to Malassezia folliculitis. PEI-7 was listed in the FDA's Voluntary Cosmetic Registration Program (VCRP) in 2012.
Your Skin
Skin Compatibility
Our Assessment
Verdict
PEI-7 is a valuable anti-aging peptide that offers significant benefits in improving skin firmness, elasticity, and reducing wrinkles by targeting inflammation and promoting essential structural component synthesis, making it ideal for precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources